Obesity and female fertility: A primary care perspective

Journal of Family Planning and Reproductive Health Care

Volumn 35, Issue 3, 2009, Pages 181-185

  Wilkes, Scott ^a,c   Murdoch, Alison ^b  

^a UNIVERSITY OF SUNDERLAND   (United Kingdom)

^b INSTITUTE OF HUMAN GENETICS   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Family practice; Infertility; Obesity; Polycystic ovary syndrome; Primary care

Indexed keywords

BODY MASS; COST EFFECTIVENESS ANALYSIS; FEMALE FERTILITY; FEMALE INFERTILITY; HUMAN; INFERTILITY THERAPY; LOW CALORY DIET; MATERNAL MORBIDITY; MORTALITY; OBESITY; OVARY INSUFFICIENCY; OVARY POLYCYSTIC DISEASE; PRIMARY MEDICAL CARE; REVIEW; UNITED KINGDOM; WEIGHT REDUCTION;

BODY MASS INDEX; FAMILY PRACTICE; FEMALE; GREAT BRITAIN; HUMANS; INFERTILITY, FEMALE; OBESITY; POLYCYSTIC OVARY SYNDROME; PRIMARY HEALTH CARE; REPRODUCTIVE TECHNIQUES, ASSISTED; RISK FACTORS;

EID: 67749113408     PISSN: 14711893     EISSN: None     Source Type: Journal    
DOI: 10.1783/147118909788707995     Document Type: Review

References (60)

1. International Obesity Taskforce and International European Association for the Study of Obesity website. 2002. www.iotf.org/database/index.asp [Accessed 14 July 2008].
2. National Institute for Health and Clinical Excellence (NICE). Obesity: The Prevention, Identification, Assessment and Management of Overweight and Obesity in Adults and Children (Clinical Guideline No. 43). 2006. http://www.nice.org.uk/guidance/CG43 [Accessed 14 July 2008].
3. Counterweight Project Team. Evaluation of the Counterweight Programme for obesity management in primary care: a starting point for continuous improvement. Br J Gen Pract 2008; 58: 548-554.
4. National Institute for Health and Clinical Excellence (NICE). Fertility: Assessment and Treatment for People with Fertility Problems (Clinical Guideline No. 11). http://www.nice.org.uk/CG011 [Accessed 14 July 2008].
5. Norman RJ, Clark AM. Obesity and reproductive disorders: a review. Reprod Fertil Dev 1998; 10: 55-63.
6. Chadwick J, Mann WN. Medicine: Airs, Waters, Places (an essay on the influence of climate, water supply and situation on health). Hippocratic Writings. London, UK: Penguin Classics, 1983; 164-165.
7. Stein IF, Leventhal ML. Amenorrhoea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1934; 29: 181-191.
8. World Health Organization (WHO). 10 Things You Need to Know About Obesity. http://www.euro.who.int/Document/NUT/ObesityConf-10things-Eng.pdf [Accessed 14 November 2007].
9. Lintsen AME, Pasker-de Jong PCM, de Boer EJ, Burger CW, Jansen CAM, Braat DDM, et al. Effects of subfertility cause, smoking and body weight on the success rate of IVF. Hum Reprod 2005; 20: 1867-1875.
10. Franks S. Genetic and environmental origins of obesity relevant to reproduction. Reprod Biomed Online 2006; 12: 526-531. (Pubitemid 43674923)
11. Templeton A, Fraser C, Thompson B. The epidemiology of infertility in Aberdeen. BMJ 1990; 301: 148-152.
12. Balen AH, Dresner M, Scott EM, Drife JO. Should obese women with polycystic ovary syndrome receive treatment for infertility? BMJ 2006; 332: 434-435.
13. Kiddy DS, Sharp PS, White DM, Scanlon MF, Mason HD, Bray CS, et al. Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases. Clin Endocrinol 1990; 32: 213-220.
14. Norman RJ, Masters SC, Hague W, Beng C, Pannall P, Wang JX, et al. Metabolic approaches to the subclassification of polycystic ovary syndrome. Fertil Steril 1995; 63: 329-335.
15. Franks S. Polycystic ovary syndrome: a changing perspective. Clin Endocrinol 1989; 31: 87-120. (Pubitemid 19178148)
16. Moran LJ, Norman RJ. The obese patient with infertility: a practical approach to diagnosis and treatment. Nutr Clin Care 2002; 5: 290-297.
17. Pasquali R, Pelusi C, Genghini S, Cacciari M, Gambineri A. Obesity and reproductive disorders in women. Hum Reprod Update 2003; 9: 359-372.
18. The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41-47.
19. Bhathena RK. Therapeutic options in the polycystic ovary syndrome. J Obstet Gynaecol 2007; 27: 123-129. (Pubitemid 46457537)
20. Abbott DH, Dumesic DA, Franks S. Developmental origin of polycystic ovary syndrome - a hypothesis. J Endocrinol 2002; 174: 1-5. (Pubitemid 34830927)
21. Balen A, Conway O, Homberg R, Legro RS. Long-term sequelae of polycystic ovary syndrome. Polycystic Ovary Syndrome: A Guide to Clinical Management. London, UK: Taylor & Francis, 2005; 93-128.
22. Balen AH, Anderson RA, Policy & Practice Committee of the BFS. Impact of obesity on female reproductive health: British Fertility Society, Policy and Practice Guidelines. Hum Fertil 2007; 10: 195-206.
23. Zachariah M, Fleming R, Acharya U. Management of obese women in assisted conception units: a UK survey. Hum Fertil 2006; 9: 101-105. (Pubitemid 44018847)
24. Taylor A. ABC of subfertility: extent of the problem. BMJ 2003; 327: 434-436.
25. Rowell P, Braude P. Assisted conception. I - General principles. BMJ 2003; 327: 799-801.
26. van der Steeg JW, Steures P, Eijkemans MJ, Habbema JD, Hompes PG, Burggraaff JM, et al. Obesity affects spontaneous pregnancy chances in subfertile, ovulatory women. Hum Reprod 2008; 23: 324-328. (Pubitemid 351651248)
27. Wang JX, Davies M, Norman RJ. Body mass and probability of pregnancy during assisted reproduction treatment: retrospective study. BMJ 2000; 321: 1320-1321.
28. Crosignani PG, Ragni G, Parazzini F, Wyssling H, Lombroso G, Perotti L, et al. Anthropometric indicators and response to gonadotrophin for ovulation induction. Hum Reprod 1994; 9: 420-423. (Pubitemid 24096393)
29. Wass P, Waldenstrom U, Rossner S, Hellberg D. An android body fat distribution in females impairs the pregnancy rate of in-vitro fertilization-embryo transfer. Hum Reprod 1997; 12: 2057-2060. (Pubitemid 27462492)
30. Bellver J, Melo MA, Bosch E, Serra V, Remohi J, Pellicer A, et al. Obesity and poor reproductive outcome: the potential role of the endometrium. Fertil Steril 2007; 88: 446-451.
31. Zaadstra BM, Seidell JC, Van Noord PA, te Velde ER, Habbema JD, Vrieswijk B, et al. Fat and female fecundity: prospective study of effect of body fat distribution on conception rates. BMJ 1993; 3006: 484-487.
32. White DM, Polson DW, Kiddy D, Sagle P, Watson H, Gilling-Smith C, et al. Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women. J Clin Endocrinol Metab 1996; 81: 3821-3824. (Pubitemid 26380380)
33. Kiddy DS, Hamilton-Fairley D, Bush A, Short F, Anyaoku V, Reed MJ, et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol 1992; 36: 105-111.
34. Clark AM, Ledger W, Galletly C, Tomlinson L, Blaney F, Wang X, et al. Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum Reprod 1995; 10: 2705-2712.
35. Moran LJ, Brinkworth G, Noakes M, Norman RJ. Effects of lifestyle modification in polycystic ovarian syndrome Reprod Biomed Online 2006; 12: 569-578.
36. Confidential Enquiry into Maternal and Child Health (CEMACH). Why Mothers Die 2000-2002. London, UK: CEMACH, 2005.
37. Bellver J, Busso C, Pellicer A, Remohi J, Simon C. Obesity and assisted reproductive technology outcomes. Reprod Biomed Online 2006; 12: 562-568. (Pubitemid 43674927)
38. Hamilton-Fairley D, Kiddy D, Watson H, Paterson C, Franks S, Hamilton-Fairley D, et al. Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin. Br J Obstet Gynaecol 1992; 99: 128-131.
39. Sebire NJ, Jolly M, Harris JP, Wadsworth J, Joffe M, Beard RW, et al. Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London. Int J Obes Relat Metab Disord 2001; 25: 1175-1182. (Pubitemid 32721540)
40. Linne Y. Effects of obesity on women's reproduction and complications during pregnancy. Obes Rev 2004; 5: 137-143. (Pubitemid 38998238)
41. Galtier-Dereure F, Montpeyroux F, Boulot P, Bringer J, Jaffiol C. Weight excess before pregnancy: complications and cost. Int J Obes Relat Metab Disord 1995; 19: 443-448.
42. McClure N, McQuinn B, McDonald J, Kovacs GT, Healy DL, Burger HG, et al. Body weight, body mass index, and age: predictors of menotropin dose and cycle outcome in polycystic ovarian syndrome? Fertil Steril 1992; 58: 622-624.
43. Fridstrom M, Sjoblom P, Pousette A, Hillensjo T. Serum FSH levels in women with polycystic ovary syndrome during ovulation induction using down-regulation and urofollitropin. Eur J Endocrinol 1997; 136: 488-492. (Pubitemid 27239609)
44. Heslehurst N. Trends in maternal obesity incidence rates, demographic predictors, and health inequalities in 36 821 women over a 15-year period. Br J Obstet Gynaecol 2007; 114: 187-194. (Pubitemid 46089447)
45. Clark AM, Thornley B, Tomlinson L, Galletley C, Norman RJ. Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod 1998; 13: 1502-1505. (Pubitemid 28310484)
46. Maheshwari A, Scotland G, Bell J, McTavish A, Hamilton M, Bhattacharya S, et al. The direct health services costs of providing assisted reproduction services in overweight or obese women: a retrospective cross-sectional analysis. Hum Reprod 2009; 24: 633-639.
47. Galtier-Dereure F, Boegner C, Bringer J. Obesity and pregnancy: complications and cost. Am J Clin Nutr 2000; 71: 1242S-1248S.
48. Counterweight Project Team. Influence of body mass index on prescribing costs and potential cost savings of a weight management programme in primary care. J Health Serv Res Policy 2008; 13: 158-166.
49. Pasquali R, Antenucci D, Casimirri F, Venturoli S, Paradisi R, Fabbri R, et al. Clinical and hormonal characteristics of obese amenorrhea hyperandrogenic women before and after weight loss. J Clin Endocrinol Metab 1989; 68: 173-179. (Pubitemid 19028742)
50. Holte J, Bergh T, Berne C, Wide L, Lithell H. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 1995; 80: 2586-2593.
51. Galletly C, Clark A, Tomlinson L, Blaney F. Improved pregnancy rates for obese, infertile women following a group treatment program. An open pilot study. Gen Hosp Psychiatry 1996; 18: 192-195. (Pubitemid 26158665)
52. Brown I, Thompson J, Tod A, Jones G. Primary care support for tackling obesity: a qualitative study of the perceptions of obese patients. Br J Gen Pract 2006; 56: 666-672. (Pubitemid 44390239)
53. Nelson P, Adamson A, Moore H. Conducting randomised controlled trials in primary care: lessons from an obesity management trial. Br J Gen Pract 2006; 56: 674-679. (Pubitemid 44390240)
54. Lord JM, Norman R. Obesity, polycystic ovary syndrome, infertility treatment: lifestyle modification is paramount. BMJ 2006; 332: 609. (Pubitemid 44365769)
55. Balen AH, Rutherford AJ. Managing anovulatory infertility and polycystic ovary syndrome. BMJ 2007; 335: 663-666. (Pubitemid 47548459)
56. Kousta E, White DM, Franks S. Modern use of clomiphene citrate in induction of ovulation. Hum Reprod Update 1997; 3: 359-365. (Pubitemid 27515543)
57. Merhi ZO, Merhi ZO. Weight loss by bariatric surgery and subsequent fertility. Fertil Steril 2007; 87: 430-432. (Pubitemid 46176937)
58. Ramsay JE, Greer I, Sattar N. ABC of obesity. Obesity and reproduction. BMJ 2006; 333: 1159-1162.
59. Wadden TA. Treatment of obesity by moderate and severe caloric restriction. Results of clinical research trials. Ann Intern Med 1993; 119: 688-693.
60. National Health Service. 'Change for Life' website. http://www.nhs.uk/ Change4Life [Accessed 8 April 2009].